Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) — The “North America Genomics in Cancer Care Market Size, Share & Trends Analysis by Application, Product, Technology, and Country with Growth Forecasts, 2024-2031” report has been added to ResearchAndMarkets.com’s offering.
The North America Genomics in Cancer Care Market is projected to witness market growth of 15% CAGR during the forecast period (2024-2031).
The US market dominated the North America Genomics In Cancer Care Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $13.04 billion by 2031. The Canadian market is experiencing a CAGR of 17.5% during (2024-2031). Additionally, the Mexican market is forecast to exhibit a CAGR of 16.5% during (2024-2031).
List of Key Companies Profiled in the North America Genomics in Cancer Care Market
- Agilent Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- GE HealthCare Technologies, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
Market Report Segmentation
- By Application
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Research
- By Product
- Instruments
- Consumables
- Services
- By Technology
- PCR
- Genome Sequencing
- Microarrays
- Nuclei Acid Extraction & Purification
- Others
- By Country
- U.S.
- Canada
- Mexico
- Rest of North America
For more information about this report visit https://www.researchandmarkets.com/r/xkio2o
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- north-america-genomics-in-cancer-care-market-size.jpg
